Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: Seroprevalence of Leptospirosis in Val Müstair, Switzerland

View source ↗

Summary

A completed clinical trial update from University Hospital Basel reports seroprevalence data for Leptospirosis, Hepatitis E, and Tularemia in Val Müstair, Switz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Leptospirosis, Hepatitis E Virus Infection | Status: COMPLETED